期刊文献+

RNA干扰hTR基因对膀胱尿路上皮癌BIU-87细胞株端粒酶活性的影响 被引量:9

RNA interference of the hTR gene inhibits telomerase activity of bladder cancer BIU-87 cell line
下载PDF
导出
摘要 目的:探索RNA干扰(RNAi)hTR基因对膀胱尿路上皮癌BIU-87细胞株端粒酶活性的影响,为膀胱尿路上皮癌基因治疗提供新的途径及依据。方法:构建以hTR基因为靶点的RNA干扰装置PhTR-siRNA,对其进行筛选和鉴定;检测PhTR-siRNA对BIU-87细胞的生物学效应,包括抑制BIU-87细胞的生长情况、端粒酶活性检测、实时定量PCR(RealTime-PCR)验证hTR变化。结果:PhTR-siRNA干扰hTR基因后膀胱尿路上皮癌BIU-87细胞株的生长受到抑制,明显抑制端粒酶活性,实时定量PCR验证hTR基因明显减少。结论:RNA干扰hTR基因能明显抑制膀胱尿路上皮癌BIU-87细胞株的生长,可作为一种膀胱尿路上皮癌的基因治疗方法。 To investigate the influence of RNA interference of the hTR gene (RNAi-hTR) on the telomerase activity of the bladder cancer BIU-87 cell line. Methods : We constructed, screened and identified the RNAi system-PhTR-siRNA targeting hTR, analyzed the biological effect of PhTR-siRNA on BIU-87 cells, including its inhibition of their growth, determined telomerase activity and detected the changes of the hTRgene by RT-PCR. Results: RNAi-hTRobviously inhibited the growth of bladder cancer BIU-87 cells, suppressed telomerase activity and markedly decreased the hTR gene. Conclu- sion : RNAi-hTR can considerably inhibit the growth of bladder cancer BIU-87 cells. It may be one of the most promising gene therapeutic strategies for bladder cancer.
出处 《医学研究生学报》 CAS 2009年第6期587-591,I0004,共6页 Journal of Medical Postgraduates
基金 江苏省博士后科研基金资助计划基金资助项目(批准号:2004B) 江苏省“六大人才高峰”重点课题基金资助项目(批准号:2005A2)
关键词 端粒酶 RNA干扰 HTR 基因 膀胱尿路上皮癌 Telomerase RNAi Human telomerase RNA Gene Bladder cancer
  • 相关文献

参考文献16

  • 1朱圣明,王艳萍,陈晓禾,唐小军,肖文.人端粒酶催化亚单位启动子驱动的EGFP真核表达载体的构建及在肺癌细胞的表达[J].医学研究生学报,2007,20(2):123-127. 被引量:11
  • 2Connor J, Bannerji R,Saito S, et al. Regression of bladder tumors in mice treated with IL-2 gene-modified tumor cells[ J]. Exp Med 1993,177(4) :1127-1134.
  • 3Xu HJ,Zhou Y, Seigne J,et al. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein [ J ]. Cancer Res 1996,56 ( 10 ) :2245-2249.
  • 4Miyake H, Hara I, Hara S,et al, Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated p53 gene transfer in human bladder cancer model [ J]. Urology, 2000,56(4) :332-336.
  • 5Grim J, Amico A, Frizells S, et al. Adenovirus- mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemorcsistance to cisplatin and paclitaxel [ J ]. Clin Cancer Res 1997,3( 12( Part 1 ) ) :2415-2423.
  • 6Irie A, Anderegg B, Kashani-Sabet M, et al. Therapeutic efficacy of an adenovirus- mediated anti-H-ras ribozyme in experimental bladder cancer [ J ]. Antisense Nucleic Acid Drug Dev, 1999,9 (4) :341-349.
  • 7Horiguchi Y, Kosugi M, Kikuchi E, et al. Therapeutic impact of NF-kB Inhibitor against human bladder cancer in murine xenograft model [ J ]. Urology, 2006,68 ( 1 ) Suppl : 131.
  • 8Boyd M, Mairs SC, Stevenson K, et al. Transfectant mosaic spheroids: a new model for evaluation of bystander effects in experimental gene therapy[J]. J Gene Med, 2002,4( 1 ) :1-10.
  • 9Boyd M, Mairs RJ, Keith WN, et al. An efficient targeted radiotherapy/ gene therapy strategy ntilising human telomerase promoters and radioastatine and harnessing radiation mediated bystander effects[ J]. J Gene Med, 2004,6(8) : 937 -947.
  • 10Aoki Y, Cioea DP, Oidaira H, et al. RNA interference may be more potent than antisense RNA in human cancer cell lines [ J]. Clin Exp Pharmacol Physiol, 2003,30( 1 ) :96-102.

二级参考文献37

共引文献22

同被引文献113

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部